Links to Data sources

Sr. No Display Name Type Country Last Updated
1 IPCI Data Source Netherlands 26/08/2021

Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Multinational, multi-database drug utilization study of indacaterol/glycopyrronium bromide in Europe Ms Novartis Clinical Disclosure Officer 22/02/2021
Finalised Multinational, multi-database drug utilization study of inhaled NVA237 in Europe Ms Clinical Disclosure Officer Novartis 23/11/2020
Finalised Multinational, multi-database cohort study to assess adverse cardiovascular and cerebrovascular outcomes and mortality in association with inhaled NVA237 in Europe Ms Clinical Disclosure Officer Novartis 18/11/2020
Finalised European Program of Post-Authorization Safety Studies for Protelos®/Osseor® through EU-ADR Alliance Dr Daniel Prieto-Alhambra 22/03/2018
Finalised Identification of type 2 diabetes cases in a set of databases participating to the EMIF project Dr Roberto Giuseppe 11/12/2017
Finalised Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of pertussis and pertussis related outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children Professor Miriam Sturkenboom 27/11/2017
Finalised ADVANCE POC Study Protocol - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case. Coverage rates of acellular and whole-cell pertussis-containing vaccines in preschool children Dr Hanne-Dorthe Emborg 24/11/2017
Finalised ADVANCE POC I Risk pillar - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of safety outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children Dr Daniel Weibel 22/11/2017
Finalised Safety Evaluation of Adverse Reactions in Diabetes - Comparative studies Professor Miriam Sturkenboom 25/08/2017
Finalised Safety Evaluation of Adverse Reactions in Diabetes - Drug utilisation studies Professor Miriam Sturkenboom 25/08/2017
Finalised Arrhythmogenic Potential of Drugs Professor Miriam Sturkenboom 25/08/2017
Finalised Patterns and Determinants of Use of Oral Contraceptives in the European Union Professor Miriam Sturkenboom 25/08/2017
Finalised Risk of cardiac valve disorders associated with the use of biphosphonates Professor Miriam Sturkenboom 25/08/2017
Finalised Monitoring the effectiveness of risk minimisation in patients treated with pioglitazone-containing products Professor Henrik Toft Sørensen 15/12/2016
Ongoing Estimating prevalence and incidence of acute myocardial infarction in a set of heterogeneous sources of observational health data collaborating in the EMIF Platform Dr Roberto Giuseppe 14/02/2019
Ongoing The European Drug-induced Agranulocytosis Consortium Study Dr Pär Hallberg 18/12/2013